Women known to be at an increased genetic risk for developing OC, based on germline BRCA1/2 mutation carrier status, are offered risk-reducing salpingo–oophorectomy (RRSO), which reduces the risk of ovarian cancer by 71–96% (34–39). This evidence concerns the gene BRCA1 and ovarian carcinoma.